Standout Papers

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease s... 2000 2026 2008 2017 588
  1. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis (2000)
    Timothy M. Cox, Robin Lachmann et al. The Lancet

Immediate Impact

2 by Nobel laureates 6 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Design and Application of Fluorescent Probes to Detect Cellular Physical Microenvironments
2024 Standout
Physiology and diseases of tissue-resident macrophages
2023 StandoutNature
12 intermediate papers

Works of C. E. Hollak being referenced

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis
2000 Standout

Author Peers

Author Last Decade Papers Cites
C. E. Hollak 573 273 11 348 7 710
Helen Christomanou 598 338 161 9 704
J Kreysing 412 359 115 12 638
V. Gieselmann 436 393 154 9 705
Gloria N. Sando 295 443 166 9 727
Martha Sattler 544 354 215 14 652
Jessica Krakow 248 389 115 12 840
Mariana Blanco 580 117 136 13 666
Marie T. Vanier 495 181 193 9 609
Caterina Porto 484 201 219 11 607
Allan Powe 511 330 280 9 715

All Works

Loading papers...

Rankless by CCL
2026